AMORPHOUS FORM OF EMPAGLIFLOZIN AND PROCESS FOR PREPARATION THEREOF The invention provides an amorphous form of empagliflozin of formula (I) and a process for the preparation thereof. The invention also provides a pharmaceutical composition comprising an amorphous form of empagliflozin together with one or more of pharmaceutically acceptable carriers, excipients and diluents. (I)